AI-generated analysis. Always verify with the original filing.
KALA BIO, Inc. filed an 8-K on February 20, 2026, disclosing that David Lazar notified the company on February 16, 2026, regarding Item 5.02 matters related to departure of directors or principal officers, election of directors, or appointment of principal officers. Specific details of the notification were not provided in the document.
Event Type
Disclosure
Mandatory
Variant
8-K
. Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers. On February 16, 2026, David Lazar notified KALA BIO, I
David Lazar
Effective: 2026-02-16
Item 5.02 matters